Oxford-based Oxbotica will use the funding to accelerate commercial deployment of its autonomy software platform across multiple industries and key markets.
The team of medical research and bioethics experts say if such an app was rapidly and widely deployed it could significantly help to contain the spread of coronavirus.
We use cookies so we can provide you with the best online experience. By continuing to browse this site you are agreeing to our use of cookies. Click on the banner to find out more.